Clinical Trial Update: Phase I/II Study of hLL1 in Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study of hLL1 in multiple myeloma has completed its phases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• hLL1

Snippet

Sponsor: Gilead Sciences | Conditions: Multiple Myeloma, Myeloma, Plasma-Cell | Phase 1, Phase 2 | Status: COMPLETED